Q2 2020 EPS Estimates for AdaptHealth Corp. (NASDAQ:AHCO) Increased by Analyst

AdaptHealth Corp. (NASDAQ:AHCO) – SVB Leerink upped their Q2 2020 earnings per share estimates for shares of AdaptHealth in a research report issued to clients and investors on Monday, July 6th. SVB Leerink analyst D. Ha now forecasts that the company will post earnings per share of $0.18 for the quarter, up from their previous estimate of $0.17. SVB Leerink currently has a “Outperform” rating and a $21.00 target price on the stock. SVB Leerink also issued estimates for AdaptHealth’s Q3 2020 earnings at $0.15 EPS, FY2020 earnings at $0.56 EPS, Q2 2021 earnings at $0.20 EPS, Q3 2021 earnings at $0.19 EPS, Q4 2021 earnings at $0.22 EPS, FY2021 earnings at $0.73 EPS and FY2022 earnings at $0.93 EPS.

A number of other research analysts have also issued reports on AHCO. Stifel Nicolaus increased their target price on shares of AdaptHealth from $18.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, May 27th. Royal Bank of Canada assumed coverage on shares of AdaptHealth in a research report on Tuesday, June 9th. They set an “outperform” rating and a $24.00 target price on the stock. Finally, Zacks Investment Research upgraded shares of AdaptHealth from a “hold” rating to a “buy” rating and set a $23.00 target price on the stock in a research report on Tuesday. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $20.33.

Shares of NASDAQ:AHCO opened at $19.44 on Wednesday. The company’s 50 day moving average price is $17.23 and its two-hundred day moving average price is $15.19. AdaptHealth has a 12-month low of $7.82 and a 12-month high of $22.57. The firm has a market cap of $934.97 million, a PE ratio of 64.80 and a beta of -0.17.

AdaptHealth (NASDAQ:AHCO) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.11 EPS for the quarter, missing the Zacks’ consensus estimate of $0.12 by ($0.01). The company had revenue of $191.44 million for the quarter, compared to analyst estimates of $177.41 million.

Several hedge funds and other institutional investors have recently bought and sold shares of AHCO. Harbor Investment Advisory LLC acquired a new stake in shares of AdaptHealth during the 1st quarter worth approximately $28,000. Citigroup Inc. boosted its position in shares of AdaptHealth by 129.0% during the 1st quarter. Citigroup Inc. now owns 2,137 shares of the company’s stock worth $34,000 after acquiring an additional 1,204 shares in the last quarter. BlackRock Inc. acquired a new stake in shares of AdaptHealth during the 1st quarter worth approximately $103,000. Jefferies Group LLC bought a new position in AdaptHealth in the 4th quarter valued at approximately $110,000. Finally, Goldman Sachs Group Inc. bought a new position in AdaptHealth in the 4th quarter valued at approximately $203,000. Institutional investors and hedge funds own 53.85% of the company’s stock.

AdaptHealth Company Profile

AdaptHealth, LLC distributes home medical equipment. The Company offers mobility products, respiratory therapy, non- invasive ventilation, nutrition supplies, ocean home health products, sleep therapy supplies, bed lifts, seat lift chairs, and bath aids. AdaptHealth, LLC was founded in 2012 and is based in Phoenixville, Pennsylvania.

See Also: Price to Earnings Ratio (PE) Basics

Earnings History and Estimates for AdaptHealth (NASDAQ:AHCO)

Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.